Rapamycin inhibits BMP-7-induced osteogenic and lipogenic marker expressions in fetal rat calvarial cells

Journal of Cellular Biochemistry

Volumn 114, Issue 8, 2013, Pages 1760-1771

  Yeh, Lee Chuan C ^a   Ma, Xiuye ^a   Ford, Jeffery J ^a   Adamo, Martin L ^a,b   Lee, John C ^a  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

ADIPOGENIC DIFFERENTIATION; BMP 7; FRC; mTOR; OSTEOBLAST DIFFERENTIATION; RAPAMYCIN

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; OSTEOGENIC PROTEIN 1; PALMITIC ACID; RAPAMYCIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; LIPID STORAGE; LIPOGENESIS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, DIFFERENTIATION; BONE MORPHOGENETIC PROTEIN 7; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; GENE EXPRESSION REGULATION; LIPIDS; OSTEOGENESIS; RATS; SIROLIMUS; SKULL; TOR SERINE-THREONINE KINASES;

RATTUS;

EID: 84879172415     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24519     Document Type: Article

References (50)

1. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB,. 1990. Factors that promote progressive development of osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143: 213-221.
2. Asahina I, Sampath TK, Hauschka PV,. 1996. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222: 38-47.
3. Aubin JE,. 1998. Advances in the osteoblast lineage. Biochem Cell Biol 76: 899-910.
4. Averous J, Proud CG,. 2006. When translation meets transformation: The mTOR story. Oncogene 25: 6423-6435.
5. Bellows CG, Heersche JN,. 2001. The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. J Bone Miner Res 16: 1983-1993.
6. Bradford MM,. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Chakrabarti P, English T, Shi J, Smas CM, Kandror KV,. 2010. Mammalian target of rapamycin complex 1 suppresses lipolyisis, stimulates lipogenesis, and promotes fat storage. Diabetes 59: 775-781.
8. Chen TL, Shen WJ, Kraemer FB,. 2001. Human BMP-7/OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures. J Cell Biochem 82: 187-199.
9. Chen D, Zhao M, Mundy GR,. 2004. Bone morphogenetic proteins. Growth Factors 22: 233-241.
10. Chibalin AV, Leng Y, Vieira E, Krook A, Bjornholm M, Long YC, Kotova O, Zhong Z, Sakane F, Steiler T, Nylen C, Wang J, Laakso M, Topham MK, Gilbert M, Wallberg-Henriksson H, Zierath JR,. 2008. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132: 375-386.
11. Derynck R, Zhang YE,. 2003. Smad-dependent and Smad-independent pathways in TGF-b family signaling. Nature 425: 577-584.
12. Ducy P,. 2011. The role of osteocalcin in the endocrine cross-talk between bone remodeling and energy metabolism. Diabetologia 54: 1291-1297.
13. Elbaz A, Wu X, Rivas D, Gimble JM, Duque G,. 2010. Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 14: 982-991.
14. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych, GA, Calhoun JH, LaForte AJ, Yin S,. 2001. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83A (Suppl 1): S151-S158.
15. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL,. 1999. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14: 1522-1535.
16. Hasegawa T, Oizumi K, Yoshiko Y, Tanne K, Maeda N, Aubin JE,. 2008. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations. BMC Devel Biol 8: 71.
17. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers, SA,. 2007. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179.
18. Isomoto S, Hattori K, Ohgushi H, Nakajima H, Tanaka Y, Takakura Y,. 2007. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci 12: 83-88.
19. Kang Q, Song WX, Luo Q, Tang N, Luo JY, Luo X, Chen J, Bi Y, He BC, Park JK, Jiang W, Tang Y, Huang J, Su Y, Zhu GH, He Y, Yin H, Hu Z, Wang Y, Chen L, Zuo GW, Pan XC, Shen J, Vokes T, Reid RR, Haydon RC, Luu HH, He TC,. 2009. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cell Develop 18: 545-559.
20. Karsenty G, Oury F,. 2012. Biology without walls: The novel endocrinology of bone. Annu Rev Physiol 74: 87-105.
21. Kim M, Choe S,. 2011. BMPs and their clinical potentials. BMB Reports 44: 619-634.
22. Kishimoto K, Kato A, Osada S, Nishizuka M, Imagawa M,. 2010. Fad104, a positive regulator of adipogenesis, negatively regulates osteoblast differentiation. Biochem Biophys Res Commun 397: 187-191.
23. Langenfeld EM, Kong Y, Langenfeld J,. 2005. Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Mol Cancer Res 3: 679-684.
24. Laplante M, Sabatini DM,. 2010. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc Natl Acad Sci USA 107: 3281-3282.
25. Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, Cho YS,. 2010. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cell Develop 19: 557-568.
26. Li S, Brown MS, Goldstein JL,. 2010. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 107: 3441-3446.
27. Martin SK, Fitter S, Bong LF, Drew JJ, Gronthos S, Shepherd PR, Zannettino AC,. 2010. NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells. J Bone Miner Res 25: 2126-2137.
28. Massague J,. 2000. How cells read TGF-beta signals. Nature Rev Mol Cell Biol 1: 169-178.
29. McCarthy TL, Centrella M, Canalis E,. 1988. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3: 401-408.
30. Mikami Y, Lee M, Irie S, Honda MJ,. 2011. Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria-derived cells. J Cell Physiol 226: 739-748.
31. Mukherjee A, Rotwein P,. 2009. Akt promotes BMP-2 mediated osteoblast differentiation and bone development. J Cell Sci 122: 716-726.
32. Niziolek PJ, Murthy S, Ellis SN, Sukhija KB, Hornberger TA, Turner CH, Robling AG,. 2009. Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent Parathyroid Hormone treatment. J Cell Physiol 221: 579-585.
33. Nye C, Kim J, Kalhan SC, Hanson RW,. 2008. Reassessing triglyceride synthesis in adipose tissues. Trends Endo Metab 19: 356-361.
34. Ogawa T, Tokuda M, Tomizawa K, Matsui H, Itano T, Konishi R, Nagahata S, Hatase O,. 1998. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells. Biochem Biophys Res Commun 249: 226-230.
35. Schwetz V, Pieber T, Obermayer-Pietsch B,. 2012. The endocrine role of the skeleton: Background and clinical evidence. Eur J Endo 166: 959-967.
36. Shoba LNN, Lee JC,. 2003. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks Osteogenic Protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells. J Cell Biochem 88: 1247-1255.
37. Singha UK, Jiang Y, Yu S, Luo M, Lu Y, Zhang J, Xiao G,. 2008. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 103: 434-446.
38. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ,. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
39. Steenhuis P, Carr KM, Pettway GJ, Ignelzi MA,. 2009. Osteogenic and adipogenic cell fractions isolated from postnatal mouse calvaria. Cells Tissues Organs 190: 150-157.
40. ten Dijke P, Fu J, Schaap P, Roelen BA,. 2003. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85A (Suppl 3): 34-38.
41. Vinals F, Lopez-Rovira T, Rosa JL, Ventura F,. 2002. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett 510: 99-104.
42. Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T, Crane J, Frassica F, Zhang L, Rodriguez JP, Jia X, Yakar S, Xuan S, Efstratiadis A, Wan M, Cao X,. 2012. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18: 1095-1101.
43. Yeh LCC, Adamo ML, Kitten AM, Olson MS, Lee JC,. 1996. Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells. Endocrinology 137: 1921-1931.
44. Yeh LCC, Adamo ML, Olson MS, Lee JC,. 1997. Osteogenic protein-1 and insulin-like growth factor synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138: 4181-4190.
45. Yeh LCC, Unda R, Lee JC,. 2000. Osteogenic Protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185: 87-97.
46. Yeh LCC, Zavala MC, Lee JC,. 2006. C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation. J Cell Biochem 97: 494-500.
47. Yeh LCC, Ma X, Matheny RW, Jr., Adamo ML, Lee JC,. 2010. Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation. Growth Factors 28: 318-328.
48. Yoshiko Y, Oizumi K, Hasegawa T, Minamizaki T, Tanne K, Maeda N, Aubin JE,. 2010. A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model. PLoS ONE 5: e11782.
49. Zhang YE,. 2009. Non-Smad pathways in TGF-β signaling. Cell Res 19: 128-139.
50. Zoncu R, Efeyan A, Sabatini DM,. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.